Introducing the MiniMed® 530G with Enlite

MiniMed® 530G System

Featuring Exclusive SmartGuardTM Technology for Advanced Protection against Lows*.

MiniMed® 530G with Enlite®
SmartGuard™ Technology
The MiniMed 530G system is an insulin pump that is fully integrated with a glucose sensor to provide advanced diabetes control. It is the only diabetes management system with Threshold Suspend – SmartGuard™ technology that takes action and automatically suspends insulin delivery when sensor glucose values reach a preset low threshold.
Better Protection with Enlite1 Sensor
  • Enlite sensor is our most accurate glucose sensor.**, 2, 3
  • The Enlite sensor drives action to keep patients within their target range.
 
*  Measured by sensor glucose values.
** Approved by the FDA in the United States
1 Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy:
  a randomized controlled trial. Diabetologia. 2012;55:3155-3162.
2 Paradigm® REAL-TIme Revel™ User Guide.
3 Enlite® Sensor Performance Clinical Appendix.
 

SmartGuard Technology

SmartGuard Technology:
Advanced protection against lows
  • SmartGuard technology automatically stops insulin delivery when sensor glucose values reach a preset low threshold.
  • SmartGuard technology* can take action for your patients when they are unable to respond to Threshold Suspend alarm.
  • Patients who use the MiniMed System with SmartGuard technology experience about 50% fewer nighttime lows* than those using a pump and sensor alone.1
  • Patients who use SmartGuard Technology with the threshold suspend automation feature feel more confident in managing their diabetes. In fact, 93% of MiniMed 530G system users say the Threshold Suspend feature lets them feel more secure in treating their diabetes.2
Watch how threshold suspend automation
How it works:
User settable: On/Off
Threshold range: 60 - 90 mg/dL
Suspends at threshold for up to 2 hours
During suspend:
  • No boluses can be administered
  • Patient can resume basal insulin delivery at any time
If sensor glucose value is below threshold at 4 hours after resuming from a full 2-hour suspend, pump re-suspends insulin delivery after the set Low Repeat time has been reached.

Download Brochure

 
* Measured as sensor glucose values.
** Data from only the voluntary CareLink® Personal Uploads from MiniMed 530G system in US available from Oct 15, 2013 to Jun 25, 2015 evaluated.
^ 26,053 patients kept SmartGuard™ feature ON 100% of time and 4,817 patients kept SmartGuard™ feature OFF 100% of time. 8,349 patients had time in both ON and OFF. SmartGuard™ techology includes Threshold Suspend. 13,166 patients had SmartGuard™ feature OFF.
1 Dexcom data from poster. Nakamura K. et al. Poster Presented at ADA 2015, June 6, 2015. Boston, MA
2 User evaluations. Data on file, Medtronic MiniMed, Inc., Northridge, CA.
 

Advanced Protection

An integrated system that is clinically proven:
  • to lower A1C without increasing risk of going low1, 2
  • to offer better control than Multiple Daily Injections (MDI) or conventional insulin pumps1, 2

Get the complete glucose picture with Continuous Glucose Monitoring (CGM)
  • Identify trends and make therapy adjustments
  • Have greater confidence with real-time alerts3
  • Gain insights about your patients' glucose trends
 
Study used previous generation SAP pumps without Threshold suspend feature versus MDI.
1 Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med.
  2010;363:311–320.
2 Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy:
  a randomized controlled trial. Diabetologia. 2012;55:3155-3162.
3 User evaluations. Data on file, Medtronic MiniMed, Inc., Northridge, CA.
 

Pump Settings

Only 5 settings need to be programmed into the insulin pump to begin therapy

Settings calculated using standard formulas

  • Basal Rate
  • Insulin-to-Carb Ratio (ICR)
  • Insulin Sensitivity Factor (ISF)
MiniMed 530G Insulin Pump
MiniMed 530G Insulin Pump
Settings determined using patient history / clinical judgment

  • Blood Glucose (BG) Target Range
  • Active Insulin Time
 
 

Pump Features

MiniMed® 530G insulin pump has 3 features to help patients achieve better glucose control1

MiniMed 530G Insulin Pump
MiniMed 530G Insulin Pumps
Rapid-acting insulin
  • Small doses of rapid-acting insulin, in immediate succession, maintain consistent pharmacodynamics
Bolus Wizard calculator
  • Calculates the amount of insulin needed for boluses (food and correction)
  • Tracks 'active' insulin
Delivers insulin in 2 ways:
BASAL INSULIN DELIVERY:
  • Replaces long-acting insulin
  • Covers hepatic glucose production and maintains glycemic stability in fasting states (between meals and overnight)
  • Automatically delivers precise, programmed dose
  • Adjustable to match diurnal variations

BOLUS INSULIN DELIVERY:
  • Covers food intake and corrects high Blood Glucose (BG) levels
 
1 User evaluations. Data on file, Medtronic MiniMed, Inc., Northridge, CA.